Recro Pharma competitors

Recro Pharma's competitors include Sucampo Pharmaceuticals, Array BioPharma, Clinigen Group and Mast Therapeutics
Add company...
Recro Pharma
Recro Pharma is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post operative pain.
Sucampo Pharmaceuticals
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Founding Date
Founding Date
2006
Founding Date
1996
Founding Date
1998
Founding Date
2010
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Malvern, US HQ
Locations
Rockville, US HQ
Kita Ward, JP
Chiyoda, JP
Chuo Ward, JP
Sanda Shi, JP
Zug, CH
Milton, GB
Locations
Boulder, US HQ
Boston, US
Charlotte, US
Phoenix, US
Detroit, US
New York, US
Houston, US
see more
Locations
Burton upon Trent, GB HQ
Locations
San Diego, US HQ
Employees
Employees
195
Employees
139
Employees
209
Employees
465200% increase
Employees
14133% increase
Valuation ($)
Valuation ($)
107.7 m
Valuation ($)
1.2 b
Valuation ($)
4.1 b
Valuation ($)
1.8 b
Valuation ($)
371.8 m
Twitter followers
Twitter followers
N/A
Twitter followers
242
Twitter followers
N/A
Twitter followers
1.2 k
Twitter followers
873

Financial

Revenue (est.)
Revenue (est.)
$71.8m (FY, 2017)
Revenue (est.)
$230.1m (FY, 2016)
Revenue (est.)
$137.9m (FY, 2016)
Revenue (est.)
£302.3m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$38.2m (FY, 2017)
Cost of goods
$76m (FY, 2016)
Cost of goods
N/A
Cost of goods
£179.6m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$33.6m (FY, 2017)
Gross profit
$154.1m (FY, 2016)
Gross profit
N/A
Gross profit
£122.7m (FY, 2017)
Gross profit
N/A
Net income
Net income
($50.1m) (FY, 2017)
Net income
$18.5m (FY, 2016)
Net income
($92.8m) (FY, 2016)
Net income
£3.8m (FY, 2017)
Net income
($29.8m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Sucampo Pharmaceuticals
HQ
Rockville, US
Employees
139

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

View company
Array BioPharma
HQ
Boulder, US
Employees
209

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
Mast Therapeutics
HQ
San Diego, US
Employees
14

A San Diego-based biopharmaceutical company.

View company